HomeStock ScreenerMetropolis Healthcare

Metropolis Healthcare Current Share Price | Metropolis Healthcare Stock Screener

METROPOLIS Healthcare Service Provider
Live Share Price NSE
₹597.45
▲ 11.15 (1.90%)
2026-09-18 00:00:00
Live Share Price BSE
₹597.55
▲ 12.25 (2.09%)
2026-09-18 00:00:00
As of September 18, 2026, the live Metropolis Healthcare share price (NSE: METROPOLIS) is ₹597.45 on NSE and ₹597.55 on BSE, up 1.90% from the previous close, with shares trading between ₹582.00 and ₹602.05 in today's trading session, and a 52-week range of ₹421.75–₹2,094.50. Browse Metropolis Healthcare financial data to support your investment research. Use the Metropolis Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Metropolis Healthcare Market Cap ₹11,869.51 Cr.
METROPOLIS P/E Ratio (TTM) 59.91
Metropolis Healthcare P/B Ratio 8.24
EPS (TTM) ₹9.19
Dividend Yield 0.85%
Debt to Equity 0.15
METROPOLIS 52 Week High ₹2094.50
Metropolis Healthcare 52 Week Low ₹421.75
Operating Margin 25.00%
Profit Margin 11.78%
METROPOLIS Revenue (TTM) ₹433.00
EBITDA ₹116.00
Net Income ₹51.00
Total Assets ₹2,138.00
Total Equity ₹1,525.00

Metropolis Healthcare Current Share Price Chart

Track the current Metropolis Healthcare share price and stock price with an interactive chart. Analyse METROPOLIS price trends, trading volume, historical performance, and volatility across different timeframes — the complete Metropolis Healthcare stock quote in one place.

Metropolis Healthcare Company Profile - Fundamental Screener

Screen Metropolis Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for METROPOLIS shares.
Metropolis Healthcare Limited is an Indian diagnostic services company operating across India and Africa. Founded in 1980 as a pathology partnership, it has evolved into a public company offering a wide range of clinical laboratory tests and profiles. The company operates through a hub and spoke model with 115 clinical...more
Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E
Chairperson/CEO Ameera Sushil Shah
ISIN INE112L01020

Metropolis Healthcare Balance Sheet Screener

Screen METROPOLIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2026 2025 2024 2023 2022 2021 2020 2019 2018
Assets
Total Assets 2,138 1,867 1,555 1,502 1,530 1,004 752 553 530
Current Assets 469 346 316 303 393 609 397 305 300
Fixed Assets 1,601 1,447 1,177 1,121 1,059 343 296 213 207
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0
Current Liabilities 280 238 210 246 341 92 58 8 11
Non-Current Liabilities 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 1,525 1,335 1,099 991 888 708 525 420 429
Share Capital 42 10 10 10 10 10 10 10 10
Reserves & Surplus 1,461 1,313 1,078 978 876 696 513 409 405

Metropolis Healthcare Income Statement Screener - Profit & Revenue Analysis

Screen Metropolis Healthcare income statement and profit fundamentals. Analyze METROPOLIS quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Metropolis Healthcare share price evaluation.
Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar
Revenue 433 455 352 394 430 415 334 316 353 325 284 280 310 293 312
Expenses 317 339 283 296 321 320 251 235 260 251 212 214 234 226 231
EBITDA 116 116 69 97 109 95 83 81 93 75 72 66 76 67 81
Operating Profit % 25.00% 25.00% 18.00% 23.00% 25.00% 21.00% 24.00% 25.00% 26.00% 22.00% 25.00% 23.00% 24.00% 22.00% 24.00%
Depreciation 39 32 29 31 32 32 26 26 27 28 23 21 22 25 18
Interest 8 6 5 5 6 6 6 5 5 5 6 6 6 5 6
Profit Before Tax 70 78 36 61 71 57 51 51 61 42 42 39 48 37 57
Tax 19 21 7 16 18 15 14 13 15 11 8 10 13 10 16
Net Profit 51 57 29 45 53 42 37 38 47 32 34 29 36 27 40
EPS 2.46 2.73 5.69 8.70 10.17 7.99 7.11 7.41 9.08 6.12 6.51 5.62 6.92 5.30 7.81

Metropolis Healthcare Cash Flow Screener - Liquidity Fundamentals

Screen METROPOLIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March
Operating Activities 351 263 264 247 253 249 215 90 104 102
Investing Activities -220 -199 -89 48 -736 63 -104 36 1 -86
Financing Activities -115 -87 -181 -292 163 -33 -55 -118 -87 -17
Net Cash Flow 15 -23 -6 3 -321 279 56 8 18 -1

Metropolis Healthcare Shareholding Pattern Screener

See Metropolis Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Metropolis Healthcare promoter holding and ownership changes for METROPOLIS on TickJournal.
Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept
Promoter Holding 48.86% 48.87% 48.88% 48.89% 48.89% 48.90% 49.40% 49.43%
FII Holding 11.03% 10.43% 11.69% 12.52% 12.83% 15.29% 16.73% 18.56%
DII Holding 35.12% 35.79% 34.73% 33.10% 32.40% 30.30% 30.00% 28.02%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 4.06% 3.99% 3.87% 3.69% 4.16% 3.84% 3.34% 3.54%
Other Holding 0.93% 0.92% 0.83% 1.80% 1.72% 1.68% 0.53% 0.45%
Shareholder Count 50,636 48,488 46,670 47,846 50,015 49,293 48,572 51,852

Metropolis Healthcare Share Dividend Screener - Share Yield Analysis

Check Metropolis Healthcare dividend history with payout and yield data. View Metropolis Healthcare dividend details including ex-dates and amounts for METROPOLIS stock.
Period Dividend Per Share Dividend Yield
2026-March ₹5.00 0.85%
2025-March ₹0.00 0.00%
2024-March ₹4.00 1.02%
2023-March ₹8.00 1.86%
2022-March ₹8.00 2.56%
2021-March ₹8.00 1.57%
2020-March ₹8.00 1.43%
2019-March ₹13.26 4.13%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Metropolis Healthcare Stock Index Membership

See which indices include Metropolis Healthcare stock. Check METROPOLIS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY 500
NIFTY MIDSML 400
NIFTY SMALLCAP250 MOMENTUM QUALITY 100
NIFTY SMALLCAP250 QUALITY 50
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH

Metropolis Healthcare Market Events Screener - Corporate Actions

Get Metropolis Healthcare corporate actions including splits, bonuses, and buybacks. Check Metropolis Healthcare stock events that may affect METROPOLIS share price.
Announcement Date Record Date Event Type Information Price Impact
2026-08-18 2026-08-18 Annual General Meeting NA -2.75%
2026-08-04 2026-08-04 Quarterly Result Announcement NA 3.29%
2026-05-19 2026-05-19 Dividend ₹ 1.00 /share -7.43%
2026-05-13 2026-05-13 Quarterly Result Announcement NA 8.23%
2026-03-20 2026-03-20 Bonus 3:1 0.35%
2026-02-04 2026-02-04 Quarterly Result Announcement NA 5.61%
2025-11-11 2025-11-11 Dividend ₹ 4.00 /share -3.41%
2025-11-04 2025-11-04 Quarterly Result Announcement NA 2.62%
2025-08-13 2025-08-13 Annual General Meeting NA 7.95%
2025-08-07 2025-08-07 Quarterly Result Announcement NA 1.82%
2025-05-13 2025-05-13 Quarterly Result Announcement NA 1.03%
2025-02-04 2025-02-04 Quarterly Result Announcement NA 2.86%
2024-11-08 2024-11-08 Quarterly Result Announcement NA -0.31%
2024-08-21 2024-08-21 Annual General Meeting NA -0.32%
2023-11-17 2023-11-17 Dividend ₹ 4.00 /share 9.14%

Metropolis Healthcare Competitors Screener - Peer Comparison

Screen METROPOLIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 31,958 58.66 2,864 12.11% 510 52.85
Vijaya Diagnostic Centre 14,855 82.54 835 19.34% 173 44.95
Metropolis Healthcare 11,870 59.91 1,671 24.15% 191 48.12
Thyrocare Technologies 8,666 49.62 846 20.48% 163 37.31
Nephrocare Health Services 7,375 90.61 1,023 32.93% 77 57.75
Krsnaa Diagnostics 1,757 18.39 773 4.05% 106 43.89
Suraksha Diagnostic 1,682 48.15 314 22.55% 31 54.61
3B BlackBio DX 1,164 21.72 142 27.17% 61 49.35
One Global Service Provider 1,013 14.36 499 237.48% 70 39.84
Health X Platform 972 -37.44 1,319 12.68% -3 53.22

Metropolis Healthcare Company Announcements - News Screener

Screen METROPOLIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-09-13 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-09-11 Announcement under Regulation 30 (LODR)-Restructuring -
2026-09-11 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 -
2026-09-02 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-08-27 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-08-27 Disclosure Under Regulation 30 Of SEBI Listing Regulations -
2026-08-27 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-08-20 Announcement under Regulation 30 (LODR)-Restructuring -
2026-08-20 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-19 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-18 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-13 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-08-13 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-08-10 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-08-05 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-08-05 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-04 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-08-04 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-08-04 Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026 -
2026-08-04 Board Meeting Outcome for The Meeting Held Today (August 04 2026) -